Organogenesis Holdings
ORGO
108 hedge funds and large institutions have $238M invested in Organogenesis Holdings in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 38 reducing their positions, and 16 closing their positions.
116% more call options, than puts
Call options by funds: $255K | Put options by funds: $118K
43% more capital invested
Capital invested by funds: $167M → $238M (+$71.1M)
31% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 16
4.14% more ownership
Funds ownership: 39.99% → 44.13% (+4.1%)
4% more funds holding
Funds holding: 104 → 108 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$18M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.93M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.66M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.49M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$9.33M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.35M |
| 3 |
Millennium Management
New York
|
-$1.05M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$988K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$985K |
ORGO Hedge Fund Activity: Q4 2023 in Review
108 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q4 2023, worth a combined $238M — up 43% from $167M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new ORGO positions and 16 closed out — a net gain of 5 holders — while 32 added to existing stakes and 38 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $18M. The largest seller was Soleus Capital Management, cutting an estimated $9.33M.
- 108 institutional investors held Organogenesis Holdings (ORGO) as of Q4 2023, up from 104 in Q3 2023.
- Funds reported $238M of Organogenesis Holdings stock for Q4 2023, up 43% quarter-over-quarter.
- 21 funds opened new Organogenesis Holdings positions in Q4 2023 and 16 closed out, a net change of +5 holders.
- The largest Organogenesis Holdings buyer in Q4 2023 was Morgan Stanley, an estimated $18M added.
- The largest Organogenesis Holdings seller in Q4 2023 was Soleus Capital Management, an estimated $9.33M sold.
Based on aggregated 13F filings for Q4 2023.